Europe Oligonucleotide Synthesis Market Analysis and Forecasts to 2027 by Product, Application and End User

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Oligonucleotide Synthesis Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Oligonucleotide Synthesis Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Demand for Personalized Medicine

5.2 Market Opportunities

5.2.1 Surging Investments and Advancements in DNA Synthesis by Oligonucleotide Synthesis Phosphoramidite Method

5.3 Future Trends

5.3.1 Strategic Initiatives by Market Players

5.4 Impact of Drivers and Restraints

6. Europe Oligonucleotide Synthesis Market Regional Analysis

6.1 Europe Oligonucleotide Synthesis Market Overview

6.2 Europe Oligonucleotide Synthesis Market Revenue 2016-2027 (US$ Million)

6.3 Europe Oligonucleotide Synthesis Market Forecast Analysis

7. Europe Oligonucleotide Synthesis Market Analysis – by Product

7.1 Synthesized Oligonucleotides

7.1.1 Overview
7.1.2 Synthesized Oligonucleotides: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Equipment

7.3.1 Overview
7.3.2 Equipment: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Oligonucleotide Synthesis Market Analysis – by Application

8.1 Research

8.1.1 Overview
8.1.2 Research: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Diagnostics

8.2.1 Overview
8.2.2 Diagnostics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Therapeutics

8.3.1 Overview
8.3.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Oligonucleotide Synthesis Market Analysis – by End User

9.1 Academic Research Institutes

9.1.1 Overview
9.1.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Pharmaceutical & Biotechnology Companies

9.2.1 Overview
9.2.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview
9.3.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Other End Users

9.4.1 Overview
9.4.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Oligonucleotide Synthesis Market – Europe Analysis

10.1 Europe

10.1.1 Europe Oligonucleotide Synthesis Market Breakdown, by Key Country, 2019 and 2027 (%)
10.1.1.1 Europe Oligonucleotide Synthesis Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.1.2 UK: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.1.3 UK: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.1.1.2 Germany: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.1.1.3 France: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.3.2 France: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.3.3 France: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.1.1.4 Russia: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.1.1.5 Italy: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Oligonucleotide Synthesis Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GenScript

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Molecular Assemblies

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Twist Biosciences

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Evonetix

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 DNA Script

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Nuclera Nucleics

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Camena Bioscience

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Synthomics

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Ansa Biotechnologies

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights